SEC Form 4 · accession 0001225208-19-002353
JOHNSON & JOHNSON · JNJ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer L Taubert
Officer — EVP, WW Chair, Pharmaceuticals
Period of report
Feb 8, 2019
Accepted (ET)
Feb 12, 2019 · 9:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000200406
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 8, 2019 | M | 8,529 | $0.00 | A | 72,205 | D | |
| Common StockF2 | Feb 8, 2019 | F | 3,565 | $132.00 | D | 68,640 | D | |
| Common StockF3 | Feb 11, 2019 | M | 9,748 | $0.00 | A | 78,388 | D | |
| Common StockF4 | Feb 11, 2019 | A | 1,599 | $0.00 | A | 79,987 | D | |
| Common StockF5 | Feb 11, 2019 | F | 6,236 | $131.94 | D | 73,751 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF1 | — | Feb 8, 2019 | M | 8,529 | D | Feb 8, 2019 | — | Common Stock | 8,529 | 0 | D |
| Employee Stock Options (Right to Buy)F6 | $131.94 | Feb 11, 2019 | A | 67,397 | A | Feb 11, 2022 | Feb 11, 2029 | Common Stock | 67,397 | 67,397 | D |
| Performance Share UnitsF3 | — | Feb 11, 2019 | M | 9,748 | D | Feb 8, 2019 | — | Common Stock | 9,748 | 0 | D |
| Restricted Share UnitsF7 | — | Feb 11, 2019 | A | 3,297 | A | Feb 11, 2022 | — | Common Stock | 3,297 | 3,297 | D |
Explanation of responses
- F1Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting.
- F2Shares withheld for payment of taxes upon vesting of Restricted Share Units.
- F3Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.
- F4Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board.
- F5Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.
- F6Awarded under Issuer's Long-Term Incentive Plan.
- F7Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.
Remarks
poataubert.txt